EGBN(EGBN)
EGBN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $307M | $319M | $287M |
| Low | $302M | $310M | $279M |
| High | $310M | $323M | $293M |
| EBITDA Avg | $57M | $59M | $53M |
| Low | $56M | $58M | $52M |
| High | $58M | $60M | $55M |
| EBIT Avg | $55M | $57M | $51M |
| Low | $54M | $56M | $50M |
| High | $56M | $58M | $52M |
| Net Income Avg | $53M | $79M | $113M |
| Low | $47M | $78M | $109M |
| High | $55M | $80M | $117M |
| EPS Avg | $1.70 | $2.61 | $3.75 |
| Low | $1.57 | $2.59 | $3.61 |
| High | $1.80 | $2.64 | $3.85 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 4 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $74M | $77M | $79M | $78M | $79M | $81M | $81M |
| Low | $74M | $75M | $77M | $76M | $77M | $78M | $79M |
| High | $75M | $78M | $81M | $79M | $81M | $82M | $83M |
| EBITDA Avg | $14M | $14M | $15M | $14M | $15M | $15M | $15M |
| Low | $14M | $14M | $14M | $14M | $14M | $15M | $15M |
| High | $14M | $14M | $15M | $15M | $15M | $15M | $15M |
| EBIT Avg | $13M | $14M | $14M | $14M | $14M | $14M | $15M |
| Low | $13M | $13M | $14M | $14M | $14M | $14M | $14M |
| High | $13M | $14M | $14M | $14M | $14M | $15M | $15M |
| Net Income Avg | $11M | $12M | $15M | $17M | $20M | $21M | $22M |
| Low | $9M | $11M | $14M | $17M | $19M | $21M | $21M |
| High | $12M | $13M | $15M | $18M | $20M | $22M | $22M |
| EPS Avg | $0.34 | $0.41 | $0.48 | $0.56 | $0.65 | $0.70 | $0.71 |
| Low | $0.28 | $0.36 | $0.46 | $0.54 | $0.62 | $0.67 | $0.69 |
| High | $0.40 | $0.43 | $0.49 | $0.58 | $0.66 | $0.72 | $0.73 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 4 | 3 / 2 | 3 / 2 | 2 / 1 | 2 / 1 | 3 / 2 |